Int J Cardiol. 2013 Dec 10;170(2):95-106. doi: 10.1016/j.ijcard.2013.10.038.
Heart failure is a complex clinical syndrome responsible for high morbidity and mortality in the world. Despite advances in the management of heart failure, the prognosis of these patients remains poor and there is a critical need for new treatment strategies improving the clinical outcomes. New approaches in heart failure therapies target cellular mechanisms, as well as mechanical and structural aspects of heart failure that are not addressed by recent therapies. These include abnormalities in molecular mechanisms, electrical conduction and ventricular remodeling. This review presents the pathophysiological basis, mechanisms of action and available clinical efficacy and safety data of drugs and mechanical therapies that are currently under development.
心力衰竭是一种复杂的临床综合征,在世界范围内导致高发病率和死亡率。尽管心力衰竭的治疗取得了进展,但这些患者的预后仍然不佳,因此迫切需要新的治疗策略来改善临床结果。心力衰竭治疗的新方法针对细胞机制以及心力衰竭的机械和结构方面,这些方面是最近的治疗方法所无法解决的。这些包括分子机制、电传导和心室重构的异常。本文综述了目前正在开发的药物和机械治疗方法的病理生理学基础、作用机制以及现有临床疗效和安全性数据。